Showing results (121-130 of 778) with videos related to
Sort By:
Pageof 78
Journal of Clinical Pharmacy and Therapeutics|February 26, 2016
Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysisAlemayehu B Mekonnen, Andrew J McLachlan, Jo-Anne E BrienJournal of Pharmaceutical Sciences|March 29, 2002
Muscle distribution of the neuromuscular blocker gallamine using microdialysisLucy Sasongko, Iqbal Ramzan, Kenneth M Williams, et al.BMJ Open|February 25, 2016
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysisAlemayehu B Mekonnen, Andrew J McLachlan, Jo-Anne E BrienBiostatistics (Oxford, England)|November 9, 2021
Joint frailty modeling of time-to-event data to elicit the evolution pathway of events: a generalized linear mixed model approachShu Kay Ng, Richard Tawiah, Geoffrey J Mclachlan, et al.Clinical and Translational Medicine|August 21, 2024
Extracellular vesicles as the next-generation modulators of pharmacokinetics and pharmacodynamics of medications and their potential as adjuvant therapeuticsJiaqi Liu, Joel Z Nordin, Andrew J McLachlan, et al.Neural Computation|September 15, 2016
A Universal Approximation Theorem for Mixture-of-Experts ModelsHien D Nguyen, Luke R Lloyd-Jones, Geoffrey J McLachlanBiochimica Et Biophysica Acta|December 2, 1988
One- and two-dimensional nuclear Overhauser effect studies of the electronic/molecular structure of the heme cavity of ferricytochrome b5S J McLachlan, G N La Mar, K B LeeJournal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2001
Application of a high-performance liquid chromatographic assay for the neuromuscular blocker gallamine to analysis of rat plasma, muscle and microdialysate samplesL Sasongko, I Ramzan, K M Williams, et al.Biochimica Et Biophysica Acta|September 21, 1994
Hydrogen isotope effects on the proton nuclear magnetic resonance spectrum of bovine ferricytochrome b5: axial hydrogen bonding involving the axial His-39 imidazole ligandK B Lee, S J McLachlan, G N La MarSeminars in Thrombosis and Hemostasis|January 5, 2008
Time to think outside the box? Proposals for a new approach to future pharmacokinetic studies of von Willebrand factor concentrates in people with von Willebrand diseaseEmmanuel J Favaloro, Geoff Kershaw, Andrew J McLachlan, et al.Pageof 78